Regeneron CEO 23andMe Bid - Search News

News

23andMe, Regeneron

Regeneron Backs Off 23andMe, Losing Bid to Former CEO

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.

CNBC on MSN · 8d

Regeneron CEO on 23andMe bid: Trying to balance individual privacy with biotech & genetics research

Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, privacy concerns over 23andMe's genetic data, importance of biotechnology, and more.

pharmaphorum · 3d

Former CEO wins bidding war for 23andMe, beating Regeneron

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging victorious in a bidding war for the bankrupt company.

GovInfoSecurity2d

23andMe's Co-Founder to Buy Company; Makes Privacy Pledge

TTAM Research Institute - 23andMe's co-founder and former CEO Anne Wojcicki's new company - is the winner in a final round of ...

2don MSN

Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data

Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results